NASDAQ · BBTX

Bambusa Therapeutics financials

$16.00+6.74%

Close Nov 2, 2026 · split-adjusted

Bambusa Therapeutics has no quarterly financial statements on file. Funds and some foreign issuers do not file them.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology